A Personal Nutrition Advisor to Assist Remote Dietary Counselling for Weight Loss and Maintenance
PNA-ORIGINATE
1 other identifier
interventional
81
1 country
1
Brief Summary
The purpose of the study is to assess the usability of the PNA and satisfaction with the treatment within the framework of usual care remote nutritional counselling for GLP-1-supported weight management and collect pilot data on its potential to support weight loss.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Aug 2023
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
August 18, 2023
CompletedStudy Start
First participant enrolled
August 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2024
CompletedJune 4, 2024
June 1, 2024
8 months
June 15, 2023
June 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in the overall mean satisfaction score of the Nutritional and Dietetic Patient Outcomes Questionnaire (NDPOQ)
This outcome will evaluate the patient treatment satisfaction with the counselling of the "Personal Nutrition Advisor" (PNA) -assisted remote nutritional counselling. The NDPOQ includes a 5 point likert scale of agreement (5 points=strongly agree, 1 point= strongly disagree) of 15 questions.
From baseline to 3 months of the respective study period
The overall mean score of the "perceived impact" section from the user version of the mobile application scale (uMARS )
This outcome will evaluate patient satisfaction with the counselling of the "Personal Nutrition Advisor" (PNA) -assisted remote nutritional counselling. The uMARS includes a 5 point likert scale of agreement (5 points=strongly agree, 1 point= strongly disagree) of 5 questions.
Post intervention visit (3 months after baseline)
The overall mean score of the Healthcare Systems Usability Scale (HSUS)
This outcome will evaluate dietitian reported usability of the "Personal Nutrition Advisor" (PNA)- assisted remote nutritional counselling. HSUS includes a 5 point likert scale of agreement (5 points=strongly agree, 1 point= strongly disagree) of 20 questions.
Post intervention visit (3 months after baseline)
Secondary Outcomes (15)
Change in self reported weight (%)
From baseline to 3 months of the respective study period
Proportion of patients reaching >5% weight loss
At start of the GLP-1 based pharmacotherapy to 3 months of the respective study period
Proportion of patients reaching >10% weight loss
At start of the GLP-1 based pharmacotherapy to 3 months of the respective study period
Proportion of patients reaching >15% weight loss
At start of the GLP-1 based pharmacotherapy to 3 months of the respective study period
Change in daily number of logged meals and beverages
From the first day of the respective study period to 3 months thereafter
- +10 more secondary outcomes
Study Arms (1)
Study Intervention Group
EXPERIMENTALThe study intervention group will be undergoing 3 months of Personalized Nutrition Advisor (PNA)-assisted remote nutritional counselling.The PNA data analysis tool will be used by the dietitians during remote nutritional counselling sessions.The service will be delivered to patients undergoing GLP-1 based obesity treatment as part of their usual care. The study intervention group will report treatment-satisfaction and self-efficacy via questionnaires at baseline, 1.5 - and 3 months. Patients who expressed their interest in participating in a focus group at the time of study inclusion, will be invited for a 60 min online interview session chaired by an experienced moderator. The focus group will consists of a maximum of 10 participants and address the patient's perspective on the utility of the dietitians' advice, discrepancy from expectations, general feedback and suggestions for PNA improvement using a semi structured discussion guide held in an open and spontaneous format
Interventions
The study intervention will be the use of the PNA data analysis tool during remote nutritional counselling sessions delivered by certified dietitians, also referred to as PNA-assisted remote nutritional counselling.
Eligibility Criteria
You may qualify if:
- Written informed consent
- Receiving GLP-1-based pharmacotherapy in combination with remote nutritional counselling
- Achieved weight loss of ≥5 (for baseline BMI 28-35 kg/m2) or ≥7% (for baseline BMI≥35kg/m2) after 4 months of GLP-1 based therapy (1st milestone)
You may not qualify if:
- Inability to give written informed consent
- Any physical or psychological disease or condition likely to interfere with the normal conduct of the study and interpretation of the study results
- Self-reported pregnancy, planed pregnancy within next 3 months or breast-feeding
- Concomitant participation in another trial that interferes with the normal conduct of the study and interpretation of the study results
- Not proficient in German
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lia Ballylead
Study Sites (1)
Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital
Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lia Bally, MD-PhD
Inselspital University Hospital Bern, University of Bern
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr.med. et Dr. phil.
Study Record Dates
First Submitted
June 15, 2023
First Posted
August 18, 2023
Study Start
August 25, 2023
Primary Completion
April 22, 2024
Study Completion
May 6, 2024
Last Updated
June 4, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After publication of the study results in a peer-reviewed journal
- Access Criteria
- Contact with an approval by the corresponding author
Anonymised individual participant data will be shared after inquiry via a validated sharing platform (yet to be defined). Anonymised data packages will be available once the final study results are published in a peer-reviewed journal.